Ker Yu
Fudan University(CN)National Hemophilia Foundation(US)Changchun University of Chinese Medicine(CN)Shanghai Drug Administration(CN)The Affiliated Hospital to Changchun University of Chinese Medicine(CN)
Publications by Year
Research Areas
PI3K/AKT/mTOR signaling in cancer, Protein Kinase Regulation and GTPase Signaling, Synthesis and biological activity, Biochemical and Molecular Research, Cancer Immunotherapy and Biomarkers
Most-Cited Works
- → Differential Activation of Peroxisome Proliferator-activated Receptors by Eicosanoids(1995)704 cited
- → mTOR, a novel target in breast cancer: the effect of CCI-779, an mTOR inhibitor, in preclinical models of breast cancer.(2001)418 cited
- → Ammonia Derived from Glutaminolysis Is a Diffusible Regulator of Autophagy(2010)340 cited
- → Biochemical, Cellular, and In vivo Activity of Novel ATP-Competitive and Selective Inhibitors of the Mammalian Target of Rapamycin(2009)326 cited
- → Bis(morpholino-1,3,5-triazine) Derivatives: Potent Adenosine 5′-Triphosphate Competitive Phosphatidylinositol-3-kinase/Mammalian Target of Rapamycin Inhibitors: Discovery of Compound 26 (PKI-587), a Highly Efficacious Dual Inhibitor(2010)211 cited
- → Beyond Rapalog Therapy: Preclinical Pharmacology and Antitumor Activity of WYE-125132, an ATP-Competitive and Specific Inhibitor of mTORC1 and mTORC2